Dr Reddy's Laboratories Ltd, an emerging global pharmaceutical company, has finally launched RedisparT (Doxercalci) in Indian market.

According to a press release, RedisparT is the first pro-vitamin D2 to be available in the country, which is used in the treatment of secondary hyperparathyroidism (SHPT) due to chronic kidney disease.

In addition, the drug is also used to maintain the parathyroid hormone (PTH) and calcium levels in the body in chronic kidney disease patients.

HCL Technologies, a leading offshore IT & software development company, on Wednesday reported a 42 per cent decline in its net profit at Rs 152.57 crore for the third quarter ended March 31, 2009

The firm had posted a net profit of Rs 263.08 crore in the same quarter last fiscal.

In addition, the total income of the company also fell to Rs 1,048.90 crore in the quarter under review, against Rs 1,275.58 crore in the same quarter previous fiscal.

For the nine-month ended March 31, the company has posted a net profit of Rs 804.37 crore from Rs 794.19 crore in the same period a year ago, up 1.28 per cent.

Indian Stock markets are feeling pressure for past three trading sessions. Nirmal Bang Securities has suggested two sell calls and one buy call for traders.

BHEL, The RSI has given a fresh sell signal, if the stock trade below its 13-day EMA of 1575, then sell with a stop-loss of 1630. Target price for BHEL is 1505-1440.

Moser Baer, Buy on dip and hold, huge volumes witnessed today, strong support 58-54. The stock has a major resistance at Rs 67. Buy with Target price of 69-78 in 1-5 trading sessions.

Revenue increased by 23 % YoY for fourth quarter and 19% for the year driven by improved sales numbers cloaking 37.22 lakh vehicles for the year a growth of 12% over previous year which was more than double the overall industry growth.

Operating profit increased by 33% for the quarter YoY & 26% for the year driven by decrease in the input costs mainly driven by a huge fall in the steel prices in the fourth quarter.

Other income decreased by 20% for the quarter & was down by 2% on the full year basis.

Karvy Stock Broking Limited has maintained ‘Buy’ rating on Hindustan Unilever Limited (HUL) stock to achieve an intra-day of Rs 250.

According to Karvy, day traders can buy the stock between Rs 241-242 with a stop loss of Rs 238.

Shares of the company, on Tuesday (April 21), closed at Rs 242.10 on the Bombay Stock Exchange (BSE). Current EPS & P/E ratio stood at 9.64 and 25.19 respectively. The share price has seen a 52-week high of Rs 271 and a low of Rs 185 on BSE.

Nirmal Bang, one of the leading equity research-cum-broking house, is of the view that investors can buy Television Eighteen with a target price of Rs 115-130.

According to experts at Nirmal Bang, interested traders can buy the stock on dips with a stop loss of Rs 81.

The scrip has very strong support at Rs 100.